Measuring the Incidence, Causes, and Repercussions of Protocol Amendments

Kenneth Getz; Rachael B. Zuckerman; Anne B. Cropp; Anna L. Hindle; Randy Krauss; Kenneth I. Kaitin

doi:10.1177/009286151104500307

Keywords

Protocol (science)Drug developmentMedicineIncidence (geometry)BusinessOperations managementDrugEngineeringPharmacologyAlternative medicineMathematicsPathology

Affiliated Institutions

Related Publications

Guidelines and caveats for quality of life measurement in clinical practice and research.

Harvey Schipper

"Quality of Life" is rapidly becoming part of the clinical evaluation process, both as a specific outcome measure in formal clinical trials, and as a bedside concept. This paper...

1990 PubMed 110 citations

Should there be a moratorium on the use of cholesterol lowering drugs?

George Davey Smith , Jami Pekkanen

2][3][4] The degree of disagreement is surprising as they review essentially the same data, from clinical trials of cholesterol lowering by drugs or by diet.There is agreement a...

1992 BMJ 336 citations

Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018

Olivier J. Wouters , Martin McKee , Jeroen Luyten

Importance The mean cost of developing a new drug has been the subject of debate, with recent estimates ranging from $314 million to $2.8 billion. Objective To estimate the rese...

2020 JAMA 1323 citations

SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials

An‐Wen Chan , Jennifer Tetzlaff , Douglas G. Altman +16 more

The protocol of a clinical trial serves as the foundation for study planning, conduct, reporting, and appraisal. However, trial protocols and existing protocol guidelines vary g...

2013 Annals of Internal Medicine 7216 citations

The contribution of clinical pharmacology surrogates and models to drug development—a critical appraisal

Paul Rolan

1997 British Journal of Clinical Pharmacology 95 citations

Publication Info

Year: 2011
Type: article
Volume: 45
Issue: 3
Pages: 265-275
Citations: 71
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Measuring the Incidence, Causes, and Repercussions of Protocol Amendments

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                
                                    Kenneth Getz, 
                                
                                    Rachael B. Zuckerman, 
                                
                                    Anne B. Cropp
                                
                                et al.
                            
                            (2011). 
                            Measuring the Incidence, Causes, and Repercussions of Protocol Amendments. 
                            Drug Information Journal
                            , 45
                            (3)
                            , 265-275.
                            https://doi.org/10.1177/009286151104500307
                        

Identifiers

DOI: 10.1177/009286151104500307